Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Repinotan in Patients With Acute Ischemic Stroke

ClinicalTrials.gov ID: NCT00044915

Public ClinicalTrials.gov record NCT00044915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 30, 2026, 12:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic / Pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients With Acute Ischemic Stroke

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to evaluate Repinotan HCl in patients with acute ischemic stroke. At study entry patients will be randomized to Repinotan HCl or placebo in a 1:1 ratio. The total treatment period wil be 72 hours.

Study identification

NCT ID
NCT00044915
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bayer
Industry
Enrollment
782 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2000 (Type not available)
Primary completion
Not listed
Completion
Sep 2004 (Actual)
Last update posted
Jun 12, 2009

2000 – 2004

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Not listed Los Angeles California 90024-1777 —
Not listed Oceanside California 92056-4405 —
Not listed San Diego California 92103-8765 —
Not listed San Jose California 95124 —
Not listed Boynton Beach Florida 33435-6000 —
Not listed Fort Lauderdale Florida 33308 —
Not listed Ocala Florida 34471 —
Not listed Tampa Florida 33606 —
Not listed Decatur Georgia 30033 —
Not listed Honolulu Hawaii 96813-2413 —
Not listed Des Moines Iowa 50314 —
Not listed Baltimore Maryland 21224 —
Not listed Robbinsdale Minnesota 55422-2900 —
Not listed Great Falls Montana 59405 —
Not listed Edison New Jersey 08818-3903 —
Not listed Ridgewood New Jersey 07450 —
Not listed New Hyde Park New York 11040-1496 —
Not listed Stony Brook New York 11794 —
Not listed Chapel Hill North Carolina 27599-7065 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Cleveland Ohio 44109-1998 —
Not listed Portland Oregon 97225 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Upland Pennsylvania 19013-3995 —
Not listed Beaufort South Carolina 29902-5472 —
Not listed Chattanooga Tennessee 37403-2112 —
Not listed Houston Texas 77030 —
Not listed Bellevue Washington 98004-4687 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00044915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2009 · Synced Sep 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00044915 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →